DEFA6

DEFA6 Full Name

defensin, alpha 6, Paneth cell-specific

DEFA6 Introduction

DEFA6, officially known as Defensin Alpha 6, is a small, cysteine-rich cationic peptide predominantly secreted by Paneth cells in the small intestine's crypts. As a member of the alpha-defensin subfamily, it plays a non-negotiable role in mucosal immunity. Unlike circulating defensins, DEFA6 is strictly confined to the gut lumen, where it functions as a first-line biochemical barrier. Its primary structure includes six conserved cysteine residues that form three characteristic disulfide bonds, granting it exceptional stability against proteolytic degradation. This molecular resilience allows DEFA6 to persist in the harsh, enzyme-rich environment of the digestive tract while maintaining its antimicrobial potency against a broad spectrum of enteric pathogens.The human DEFA6 gene resides on chromosome 8p23.1, within a densely packed defensin gene cluster that also houses several related alpha- and beta-defensins. Its expression is highly tissue-specific, driven by promoter elements that respond to bacterial signals and host inflammatory cytokines. Notably, DEFA6 transcription is upregulated during microbial invasion via NF-κB pathway activation, ensuring rapid peptide production when the gut faces infectious threats. Epigenetic modifications, including DNA methylation and histone acetylation, further fine-tune its expression levels, allowing for dynamic adaptation to both commensal flora shifts and pathogenic encounters. This tight genetic control prevents aberrant overexpression, which could otherwise disrupt the symbiotic equilibrium with beneficial gut microbiota.

Figure1. Structure of DEFA6.

Structural Peculiarities and Maturation Process
Synthesized as a prepropeptide, DEFA6 undergoes sequential proteolytic cleavage to attain its active tertiary conformation. The signal peptide directs it into the endoplasmic reticulum, after which the anionic prodomain is removed by tryptic enzymes, typically in the presence of zinc ions. The mature peptide adopts a canonical triple-stranded beta-sheet architecture, stabilized by its disulfide framework, which is critical for membrane insertion. Unique to DEFA6 is its preferential affinity for anionic phospholipids found in bacterial membranes, enabling selective targeting. Structural studies reveal a distinct hydrophobic patch on its surface, which facilitates oligomerization into pore-forming complexes—a mechanism that distinguishes it from other defensins that may act through different bactericidal pathways.

Functional Spectrum Beyond Microbial Killing
While its bacteriocidal activity against Salmonella, Shigella, and enterotoxigenic E. coli is well-documented, DEFA6 exerts additional immunomodulatory functions that are equally significant. At sub-lethal concentrations, it chemoattracts immature dendritic cells and memory T-lymphocytes, effectively bridging innate and adaptive immunity. Furthermore, DEFA6 has been shown to neutralize bacterial lipopolysaccharides, thus dampening excessive inflammatory responses that could lead to tissue damage. Recent evidence suggests it also contributes to intestinal epithelial barrier maintenance by enhancing tight junction protein expression. This multifunctional capacity positions DEFA6 not merely as an antibiotic peptide, but as a key homeostatic agent that balances host defense with inflammation resolution and epithelial restitution after injury.

Alternate Names for DEFA6

DEFA6; defensin, alpha 6, Paneth cell-specific; defensin-6; DEF6; HD 6; defensin 6; HD-6;